NCT04326309
- Conditions
- Asthma, Bronchial Diseases, COVID-19, +34 more
- Locations
-
- Virtual Facility The Bronx, New York, United States
Clinical trial condition
Orthomyxoviridae Infections
Explore clinical trials studying Orthomyxoviridae Infections. Study availability and eligibility vary by location and protocol.
1,810 public trials
85 recruiting studies
Orthomyxoviridae Infections trial results
NCT03814720
- Conditions
- Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +14 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
NCT03344029
- Conditions
- Flu, Infections, Influenza, +6 more
- Locations
-
- Sanofi Pasteur Investigational Site 001 Huai'an, China
NCT03391193
- Conditions
- Infections, Influenza, Influenza, Human, +5 more
- Locations
-
- Sanofi Pasteur Investigational Site 0001 Cuernavaca, Morelos, Mexico
- Sanofi Pasteur Investigational Site 0002 Ecatepec de Morelos, State of Mexico, Mexico
- Sanofi Pasteur Investigational Site 0003 Mexico City, Mexico
NCT03765437
- Conditions
- Infections, Influenza, Influenza, Human, +5 more
- Locations
-
- Investigational Site Number 7040001 Viet Tri, Vietnam
NCT03076385
- Conditions
- Infections, Influenza, Influenza, Human, +5 more
- Locations
-
- Berlin, Germany
NCT02451358
- Conditions
- Infections, Influenza, Influenza, Human, +5 more
- Locations
-
- Vadodara, Gujarat, India
- Mandya, Karnataka, India
- Pune, Maharashtra, India
- Mumbai, Parel, India
- Conditions
- Infections, Influenza, Influenza, Human, +5 more
- Locations
-
- Perm State Medical University named after Academician E. A. Wagner Perm, Russia
- LLC "Meditsinskie Tehnologii" Saint Petersburg, Russia
NCT03282240
- Conditions
- Infections, Influenza, Influenza, Human, +5 more
- Locations
-
- Sanofi Pasteur Investigational Site 037 Anaheim, California, United States
- Sanofi Pasteur Investigational Site 029 Redding, California, United States
- Sanofi Pasteur Investigational Site 003 San Diego, California, United States
- Sanofi Pasteur Investigational Site 016 Colorado Springs, Colorado, United States
Completed
Immunogenicity, Safety, Reactogenicity, Efficacy, Effectiveness and Lot Consistency of FluBlok
NCT00539981
- Conditions
- Infections, Influenza, Influenza, Human, +5 more
- Locations
-
- Impact Clinical Trials Beverly Hills, California, United States
- Benchmark Research - Sacramento Sacramento, California, United States
- Benchmark Research - San Francisco San Francisco, California, United States
- University Clinical Research, Inc Pembroke Pines, Florida, United States